FindTrial
Sign In

FDG-PET/CT

DIAGNOSTIC_TEST14 trials

Sponsors

Division of Rheumatic Diseases, National Center for Global Health and Medicine, Washington University School of Medicine, University of Utah, Jonsson Comprehensive Cancer Center, Dana-Farber Cancer Institute

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaCarcinoma, Squamous CellCervical CancerCoronavirus InfectionExtrapulmonary Tuberculosis in HIV PatientsFebrile NeutropeniaHaematopoietic Stem Cell Transplant, Allogeneic

Early Phase 1

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
CompletedNCT01894451
Dana-Farber Cancer InstituteInflammatory Breast Carcinoma
Start: 2015-06-30End: 2017-03-17Updated: 2019-12-12

Phase 1

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer
TerminatedNCT02317302
Washington University School of MedicineCervical Cancer, Uterine Cervical Cancer, Uterine Cervical Neoplasms
Start: 2011-06-28End: 2020-06-02Updated: 2020-06-11

Phase 2

Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
CompletedNCT00671437
Washington University School of MedicineCarcinoma, Squamous Cell
Start: 2008-06-30End: 2015-08-31Updated: 2017-03-14

Unknown Phase

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism
CompletedNCT01107327
University of UtahVenothromboembolism
Start: 2006-08-31End: 2012-01-31Updated: 2014-10-31
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
CompletedNCT01410630
Jonsson Comprehensive Cancer CenterLarge B Cell Diffuse Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin
Start: 2017-09-07End: 2019-10-04Updated: 2021-05-11
Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma
NCT02089204
Xuzhou Medical UniversityNasopharyngeal Carcinoma
Start: 2010-06-30End: 2015-12-31Target: 300Updated: 2014-03-17
FDG-PET/CT in Evaluation of Cytological Indeterminate Thyroid Nodules to Prevent Unnecessary Surgery (EfFECTS)
CompletedNCT02208544
Radboud University Medical CenterThyroid Neoplasms, Thyroid Nodule
Start: 2015-07-16End: 2022-02-15Updated: 2022-05-04
PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial
CompletedNCT02822014
Centre Hospitalier Universitaire Saint PierreExtrapulmonary Tuberculosis in HIV Patients
Start: 2010-02-28End: 2015-06-30Updated: 2016-07-04
Clinical value of whole-body PET/CT in patients with active rheumatic diseases.
RecruitingJPRN-UMIN000022735
Division of Rheumatic Diseases, National Center for Global Health and MedicineRheumatic diseases
Start: 2016-09-01Target: 100Updated: 2025-07-18
Molecular Evaluation in Metastatic Breast Cancer
NCT03358589
Odense University HospitalMetastatic Breast Cancer, Molecular Imaging
Start: 2017-09-01End: 2021-08-31Target: 270Updated: 2021-05-25
PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia
CompletedNCT03429387
Peter MacCallum Cancer Centre, AustraliaAcute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Febrile Neutropenia +2
Start: 2018-01-08End: 2021-01-23Updated: 2022-05-17
COvid iMaging With POSitron Emission Tomography
NCT05009563
Semmelweis University Heart and Vascular CenterCoronavirus Infection
Start: 2021-01-04End: 2022-01-04Target: 50Updated: 2021-08-17
the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis
Active, not recruitingNCT05291468
St. Antonius HospitalSarcoidosis, Pulmonary, Sarcoidosis Skin
Start: 2023-02-15End: 2026-12-01Target: 40Updated: 2026-02-12
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
RecruitingNCT06877949
Odense University HospitalMetastatic Breast Cancer, Response Monitoring
Start: 2025-04-02End: 2029-04-01Target: 420Updated: 2026-02-20

Related Papers

Evaluating the cost-effectiveness of [<sup>18</sup>F]FDG-PET/CT for investigation of persistent or recurrent neutropenic fever in high-risk haematology patients.
2023-12-151 citations
Molecular Diagnostics and [ <sup>18</sup> F]FDG-PET/CT in Indeterminate Thyroid Nodules: Complementing Techniques or Waste of Valuable Resources?
Thyroid2023-11-2711 citations
2-[<sup>18</sup>F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.
2023-04-0513 citations
[<sup>18</sup>F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules.
2022-10-178 citations
[<sup>18</sup>F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.
2022-06-2819 citations
Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
Endocrine Connections2022-06-227 citations
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
European Journal of Nuclear Medicine and Molecular Imaging2022-04-1821 citations
Quantitative classification and radiomics of [<sup>18</sup>F]FDG-PET/CT in indeterminate thyroid nodules.
2022-02-0924 citations
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
European Journal of Nuclear Medicine and Molecular Imaging2022-01-0442 citations
Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study.
2021-09-2220 citations
A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma
UNC Libraries2020-11-074 citations
Learning from patient involvement in a clinical study analyzing PET/CT in women with advanced breast cancer
Research Involvement and Engagement2020-01-0642 citations
Abstract OT2-02-03: Pilot study of zirconium-89 bevacizumab positron emission tomography for imaging angiogenesis in patients with inflammatory breast carcinoma receiving preoperative chemotherapy
Cancer Research2017-02-15
A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma
PLoS ONE2015-04-2744 citations